Left ventricular assist devices for destination therapy: OHTAC recommendation
Health Quality Ontario
Record ID 32016000558
English
Authors' recommendations:
After a review of the evidence (1), OHTAC felt that the clinical benefit of LVADs as permanent
therapy for patients with end-stage heart failure, who are ineligible for heart transplantation,
outweighed its lack of cost-effectiveness. However, because there was uncertainty about this
treatment's effect on quality of life, OHTAC requested continued quality of life data collection to
be reviewed by OHTAC in two years.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/eds/ohtas/recommendation-lvad-1602-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Heart Failure
- Heart Transplantation
- Heart-Assist Devices
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.